Finance

Lists
Why is HYL up 4,65%?
Dive Deeper
HYL:EBR
Hyloris Pharmaceuticals SA
4,28 €
+4,65%
(+0,19) 1D
16 հոկ, 17:35:05 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HYL...
Open
3,90 €
High
4,29 €
Low
3,69 €
Mkt. cap
119,84 մլն
Avg. vol.
5,76 հզր
Volume
13,85 հզր
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 մլն
No. of employees
54
Open
3,90 €
High
4,29 €
Low
3,69 €
Mkt. cap
119,84 մլն
Avg. vol.
5,76 հզր
Volume
13,85 հզր
52-wk high
8,40 €
52-wk low
3,38 €
EPS
-0,17 €
Shares outstanding
28,00 մլն
No. of employees
54
News stories
From web sources and news partners
About Hyloris Pharmaceuticals SA
CEOStijn Van Rompay
Employees54
Founded2012
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,30 մլն
2,30 մլն
2,61 մլն
2,61 մլն
Cost of goods sold
125,50 հզր
125,50 հզր
149,00 հզր
149,00 հզր
Cost of revenue
125,50 հզր
125,50 հզր
149,00 հզր
149,00 հզր
Research and development expenses
3,15 մլն
3,15 մլն
2,08 մլն
2,08 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,34 մլն
1,34 մլն
1,26 մլն
1,26 մլն
Operating expense
4,49 մլն
4,49 մլն
3,17 մլն
3,17 մլն
Total operating expenses
4,61 մլն
4,61 մլն
3,32 մլն
3,32 մլն
Operating income
-2,31 մլն
-2,31 մլն
-707,00 հզր
-707,00 հզր
Other non operating income
87,00 հզր
87,00 հզր
-3,00 հզր
-3,00 հզր
EBT including unusual items
-1,50 մլն
-1,50 մլն
-937,50 հզր
-937,50 հզր
EBT excluding unusual items
-2,20 մլն
-2,20 մլն
-700,50 հզր
-700,50 հզր
Income tax expense
-106,00 հզր
-106,00 հզր
-
-
Effective tax rate
7,09%
7,09%
-
-
Other operating expenses
-6,50 հզր
-6,50 հզր
-173,50 հզր
-173,50 հզր
Net income
-1,39 մլն
-1,39 մլն
-937,50 հզր
-937,50 հզր
Net profit margin
-60,41%
-60,41%
-35,87%
-35,87%
Earnings per share
-
-
-
-
Interest and investment income
271,00 հզր
271,00 հզր
42,00 հզր
42,00 հզր
Interest expense
-14,00 հզր
-14,00 հզր
-21,50 հզր
-21,50 հզր
Net interest expenses
257,00 հզր
257,00 հզր
20,50 հզր
20,50 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,00 մլն
-2,00 մլն
-518,50 հզր
-518,50 հզր
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps